Pharmaceuticals Acquisitions in New Hampshire

PCI Pharma Services (PCI) has acquired Lyophilization Services of New England, Inc. (LSNE), a Bedford, New Hampshire–based CDMO, from private equity firm Permira. The deal expands PCI’s global sterile fill-finish and lyophilization capabilities, adding five FDA-approved facilities (U.S. and Spain) and strengthening its end-to-end manufacturing offering for biologics and injectables.

Pace Analytical Life Sciences, a subsidiary of Pace Analytical Services, acquired Bio-Concept Laboratories, a Salem, New Hampshire-based pharmaceutical CDMO specializing in sterile aqueous formulation development and fill–finish manufacturing. The deal expands Pace’s sterile materials and ophthalmic manufacturing capabilities to better support clinical trial and drug development programs and strengthens its New England CDMO footprint.